014950 — Samik Pharm Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩100bn
- KR₩71bn
- KR₩60bn
Annual cashflow statement for Samik Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | 2,969 | 3,522 | -755 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | 229 | 1,408 | 5,078 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -2,228 | -1,897 | -3,622 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Taxes Payable | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | 2,248 | 4,385 | 2,077 |
| Capital Expenditures | -1,377 | -848 | -3,432 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | -491 | -1,313 | 2,279 |
| Sale/Maturity of Investment | |||
| Change in Net Investments | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -1,868 | -2,161 | -1,153 |
| Financing Cash Flow Items | -141 | -282 | 0 |
| Other Financing Cash Flow | |||
| Total Cash Dividends Paid | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | -250 | 253 | -256 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 131 | 2,477 | 669 |